References
- Raab MS, Podar K, Breitkreutz I, et al. Multiple myeloma. Lancet 2009;374:324–339.
- Gauduchon J, Gouilleux F, Maillard S, et al. 4-Hydroxytamoxifen inhibits proliferation of multiple myeloma cells in vitro through down-regulation of c-myc, up-regulation of p27Kip1, and modulation of Bcl-2 family members. Clin Cancer Res 2005;11:2345–2354.
- Gauduchon J, Seguin A, Marsaud V, et al. Pure antiestrogen-induced G1-arrest in myeloma cells results from the reduced kinase activity of cyclin D3/CDK6 complexes whereas apoptosis is mediated by endoplasmic reticulum-dependent caspases. Int J Cancer 2008; 122:2130–2141.
- Urbinati G, Audisio D, Marsaud V, et al. Therapeutic potential of new 4-hydroxy-tamoxifen-loaded pH-gradients liposomes in a multiple myeloma experimental model. Pharm Res 2010;27:327–339.
- Bergsagel PL, Kuehl WL, Zhan F, et al. Cyclin D dysregulation: an early and unifying pathogenic event in multiple myeloma. Blood 2005;106:296–303.
- Marsaud V, Tchakarska G, Andrieux G, et al. Cyclin K and cyclin D1b are oncogenic in myeloma cells. Mol Cancer 2010;9:103.
- Vacca A, Ribatti D. Bone marrow angiogenesis in multiple myeloma. Leukemia 2006;20:193–199.
- Moghimi SM, Szebeni J. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. Prog Lipid Res 2003;42:463–478.
- Podar K, Anderson KC. Emerging therapies targeting tumor vasculature in multiple myeloma and other hematologic and solid malignancies. Curr Cancer Drug Targets 2011;11:1005–1024.
- Caldon CE, Daly RJ, Sutherland RL, et al. Cell cycle control in breast cancer cells. J Cell Biochem 2006;97:261–274.
- Dahlman-Wright K, Cavailles V, Fuqua SA, et al. International Union of Pharmacology. LXIV. Estrogen receptors. Pharmacol Rev 2006;58:773–781.
- Maggiolini M, Picard D. The unfolding stories of GPR30 a new membrane-bound estrogen receptor. J Endocrinol 2010;204: 105–114.
- Renoir JM, Marsaud V, Lazennec G. Estrogen receptor signaling as a target for novel breast cancer therapeutics. Biochem Pharmacol2012 Oct 24. [Epub ahead of print]
- de Medina P, Payré B, Boubekeur N, et al. Ligands of the antiestrogen-binding site induce active cell death and autophagy in human breast cancer cells through the modulation of cholesterol metabolism. Cell Death Differ 2009;16:1372–1384.
- Elie N, Plancoulaine B, Signolle JP, et al. A simple way of quantifying immunostained cell nuclei on the whole histologic section. Cytometry A 2003;56:37–45.